Recombinant Human PARK7 Protein，His

PARK7, also known as DJ-1, is a multifaceted protein that plays a crucial role in cellular protection against oxidative stress and mitochondrial dysfunction, making it particularly relevant in the context of neurodegenerative diseases such as Parkinson’s disease. Mutations in the PARK7 gene are linked to early-onset familial Parkinson's, highlighting its significance in neuronal health and survival. Research into PARK7 encompasses its structure, function, and mechanisms of action, with a focus on its role as a redox-sensitive chaperone, regulating protein homeostasis and preventing cell death. Moreover, PARK7's involvement in various cellular processes, including the regulation of gene expression and the maintenance of cellular energy levels, underscores its importance in overall cellular physiology. Understanding PARK7 and developing recombinant forms of the protein can provide insights into therapeutic avenues for neurodegenerative disorders and may lead to novel biomarker identification for early diagnosis and progression monitoring. These studies are not only crucial for elucidating the molecular underpinnings of disease but also for exploring potential interventions that can enhance cellular resilience, ultimately contributing to the development of targeted therapies for patients affected by dopaminergic neuron degeneration.